v3.26.3
Revenues and Trade Receivables, Net (Tables)
 9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue
The Company's revenues were comprised of the following:
Three Months Ended September 30,Nine Months Ended
September 30,
2026202520262025
Manufacture and supply revenue$6,659 $11,467 $27,363 $28,243 
License and royalty revenue (a)
824 1,038 7,545 2,667 
Co-development and research fees74 302 914 1,098 
Proprietary product revenue, net— — — (478)
Total revenues$7,557 $12,807 $35,822 $31,530 
(a) Zevra-related one-time royalty revenues of $5,000 were recognized during the nine months ended September 30, 2026. For additional information, see Note 6, Material Agreements.
Schedule of Disaggregation of Revenue
The following table provides disaggregated net revenue by geographic area:
Three Months Ended September 30,Nine Months Ended
September 30,
2026202520262025
United States$4,608 $10,123 $28,848 $20,215 
Ex-United States2,949 2,684 6,974 11,315 
Total revenues$7,557 $12,807 $35,822 $31,530 
Schedule of Trade and Other Receivables, Net
Trade and other receivables, net consist of the following:
September 30,
2026		December 31,
2025
Trade receivables$3,702 $8,013 
Contract and other receivables1,552 9,750 
Less: sales-related allowances— (582)
Reclassification into Accrued distribution expenses and sales-related allowances
— 582 
Trade and other receivables, net$5,254 $17,763 
Schedule of Sales-related Allowances
The following tables provide a summary of activity with respect to sales-related allowances:
September 30,
2026		December 31,
2025
Balance at beginning of period
$— $48 
Provision— 568 
Payments / credits— (34)
Reclassification into Accrued distribution expenses and sales-related allowances
— (582)
Balance at end of period
$— $—